Cargando…

The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir

BACKGROUND: Currently available antiretroviral 2-drug regimen (2DR) fixed dose combinations may not be suitable for specific situations including the presence of resistance associated mutations (RAM) or drug − drug interactions (DDI). The data on the use of the non-nucleoside reverse transcriptase i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sammet, Stefanie, Touzeau-Römer, Veronique, Wolf, Eva, Schenk-Westkamp, Pia, Romano, Birgit, Gersbacher, Elke, Kastenbauer, Ulrich, Boesecke, Christoph, Rockstroh, Jürgen, Scholten, Stefan, Schneeweiss, Stephan, Roider, Julia, Seybold, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665222/ https://www.ncbi.nlm.nih.gov/pubmed/37526898 http://dx.doi.org/10.1007/s15010-023-02075-y

Ejemplares similares

1009. Dolutegravir and Doravirine in Combination: When Standard Antiretroviral Regimens are Unacceptable
por: Denyer, Rachel, et al.
Publicado: (2020)

Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis
por: Mazzitelli, Maria, et al.
Publicado: (2021)

The song of the dodo : island biogeography in an age of extinctions
por: Quammen, David, 1948-
Publicado: (1996)

Nursing and Interdisciplinary Research: Phoenix or Dodo?
por: McKenna, Hugh P
Publicado: (2020)

Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen
por: Iannone, Valentina, et al.
Publicado: (2023)

Doravirine Exposure and HIV-1 Suppression after Switching from an Efavirenz-Based Regimen to Doravirine-Lamivudine-Tenofovir Disoproxil Fumarate
por: Greaves, Wayne, et al.
Publicado: (2019)

The Dodo and Its Kindred; or the History, Affinities, and Osteology of the Dodo, Solitaire, and Other Extinct Birds of the Islands Mauritius Rodriguez, and Bourbon
Publicado: (1848)

Neither slim nor fat: estimating the mass of the dodo (Raphus cucullatus, Aves, Columbiformes) based on the largest sample of dodo bones to date
por: van Heteren, Anneke H., et al.
Publicado: (2017)

Changes in weight and BMI with first-line doravirine-based therapy
por: Orkin, Chloe, et al.
Publicado: (2021)

Correction: Neither slim nor fat: estimating the mass of the dodo (Raphus cucullatus, Aves, Columbiformes) based on the largest sample of dodo bones to date
por: van Heteren, Anneke H., et al.
Publicado: (2017)

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens
por: Maggi, Paolo, et al.
Publicado: (2023)

A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017
por: Gomez, Mario, et al.
Publicado: (2018)

The mysterious Spotted Green Pigeon and its relation to the Dodo and its kindred
por: Heupink, Tim H, et al.
Publicado: (2014)

Correction to: A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017
por: Gomez, Mario, et al.
Publicado: (2018)

El pez pulmonado, el dodó y el unicornio : una excursión por la zoología fantástica /
por: Ley, Willy, 1906-1969
Publicado: (1963)

Bone histology sheds new light on the ecology of the dodo (Raphus cucullatus, Aves, Columbiformes)
por: Angst, D., et al.
Publicado: (2017)

High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen
por: Tsai, Hung-Chin, et al.
Publicado: (2022)

Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study
por: Markopoulou, Katerina, et al.
Publicado: (2020)

Affenpocken in der Hausarztpraxis - werde ich den ersten Fall erkennen?
por: Ober, Veronica, et al.
Publicado: (2022)

Affenpocken: Werde ich den ersten Fall erkennen?: Die wichtigsten Fragen und Antworten zur meldepflichtigen Viruserkrankung
por: Seybold, Ulrich, et al.
Publicado: (2022)

Real-World Experience with Dolutegravir-Based Two-Drug Regimens
por: Ward, Douglas, et al.
Publicado: (2020)

DODO: an efficient orthologous genes assignment tool based on domain architectures. Domain based ortholog detection
por: Chen, Ting-wen, et al.
Publicado: (2010)

Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model
por: Zizioli, Daniela, et al.
Publicado: (2023)

Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens
por: Batterham, Rachel L, et al.
Publicado: (2023)

Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens
por: Rodrigues, Janine, et al.
Publicado: (2023)

Rapid point of care testing for four bacterial sexually transmitted infections using the portable isothermal loop-mediated nucleic acid amplification eazyplex platform
por: Esitgen Germaner, Ece T., et al.
Publicado: (2023)

Convex-hull mass estimates of the dodo (Raphus cucullatus): application of a CT-based mass estimation technique
por: Brassey, Charlotte A., et al.
Publicado: (2016)

Akte AIDS 2020: „Gesund bleiben mit HIV“: Editorial
por: Bogner, Johannes R., et al.
Publicado: (2020)

546. No Difference in MK-8591 and Doravirine Pharmacokinetics After Co-Administration
por: Matthews, Randolph, et al.
Publicado: (2018)

Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development
por: Martin, Elizabeth Anne, et al.
Publicado: (2020)

Specific PKG inhibitors: do they really exist?
por: Gambaryan, Stepan, et al.
Publicado: (2011)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV
por: Correa, Analú, et al.
Publicado: (2020)

Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
por: Ciccullo, Arturo, et al.
Publicado: (2019)

2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen
por: Ward, Douglas, et al.
Publicado: (2019)

Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
por: Rock, Alexander E, et al.
Publicado: (2020)

Comparison of the Efficacy and Safety of a Doravirine-Based, Three-Drug Regimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian Network Meta-Analysis
por: Zhang, Ke, et al.
Publicado: (2022)

Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine
por: Molina, Jean-Michel, et al.
Publicado: (2022)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
por: Cattaneo, Dario, et al.
Publicado: (2020)

Case study: New onset of neuropsychiatric symptoms following switching to a dolutegravir regimen
por: Badat, Ahmed, et al.
Publicado: (2022)

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
por: Wolf, Eva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4n9e2gevfae0s0nhssoifoje5h